Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,380
Closed -$223K 1859
2025
Q4
$223K Hold
7,380
﹤0.01% 882
2025
Q3
$146K Hold
7,380
﹤0.01% 1045
2025
Q2
$184K Sell
7,380
-2,784
-27% -$62.7K ﹤0.01% 903
2025
Q1
$238K Sell
10,164
-111,926
-92% -$3.24M ﹤0.01% 974
2024
Q4
$3.41M Buy
122,090
+106,513
+684% +$2.86M 0.01% 568
2024
Q3
$317K Sell
15,577
-2,158
-12% -$48.3K ﹤0.01% 781
2024
Q2
$524K Sell
17,735
-72,759
-80% -$2.09M ﹤0.01% 716
2024
Q1
$2.76M Buy
90,494
+4,079
+5% +$115K 0.01% 545
2023
Q4
$2.02M Buy
86,415
+78,135
+944% +$1.89M 0.01% 607
2023
Q3
$245K Buy
8,280
+8,050
+3,500% +$270K ﹤0.01% 808
2023
Q2
$8K Buy
+230
New +$6.44K ﹤0.01% 1478

Other funds holding CFLT

KBC Group's CFLT Position: Q1 2026 in Review

KBC Group sold out of Confluent (CFLT) in Q1 2026, closing a stake of 7,380 shares — an estimated $223K sold.

KBC Group first reported a position in CFLT in Q2 2023 and held it in 11 quarters. The position peaked at $3.41M in Q4 2024. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • KBC Group reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • KBC Group sold 7,380 Confluent shares in Q1 2026, an estimated $223K.
  • KBC Group first reported a position in Confluent in Q2 2023 and held it in 11 quarters.
  • KBC Group's Confluent position peaked at $3.41M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.